A trial of an AI algorithm that uses retina images to evaluate the risk for atherosclerotic cardiovascular disease ...
Confirmed, pooled, blinded COVID-19 events in the ongoing Phase 3 DECLARATION study of VYD2311 accumulated to date (~ 50% of study progress) can already provide sufficient statistical power to support ...
MedPage Today on MSN
Strategy Reduces Inappropriate Proton Pump Inhibitor Use
Patient- and physician-facing interventions together doubled the reductions in PPI use ...
Clinical trials are undergoing a fundamental shift as emerging technologies reshape how studies are designed, executed and evaluated. For biopharma companies, the pressure to accelerate timelines, ...
The authors updated a diagnosis list to identify low-acuity emergency department visits by veterans and applied it to examine ...
Detailed price information for Netramark Holdings Inc (AIAI-T) from The Globe and Mail including charting and trades.
Morning Overview on MSN
Oxford AI model predicts heart failure risk 5 years ahead at 86%
Every year, hundreds of thousands of people in the United Kingdom undergo a cardiac CT scan, usually to check for blocked ...
Morning Overview on MSN
AI study links thymus health to longevity and lower disease risk
Two studies published in Nature used artificial intelligence to measure the health of the human thymus from routine chest CT scans, finding that people with healthier thymus tissue lived longer and ...
Quantum technologies like quantum computers are built from quantum materials. These types of materials exhibit quantum properties when exposed to the right conditions. Curiously, engineers can also ...
Penumbra (NYSE:PEN) today announced 90-day results from the landmark STORM-PE randomized trial of its thrombectomy technology ...
The global rise in the prevalence of obesity highlights the need for accessible and effective solutions for obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results